Trials / Completed
CompletedNCT04808297
Trehalose in Subjects With Neuronal Ceroid Lipofuscinoses
A Study in Subjects With Neuronal Ceroid Lipofuscinoses Taking Trehalose
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- IRCCS Fondazione Stella Maris · Academic / Other
- Sex
- All
- Age
- 7 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Neuronal Ceroid Lipofuscinoses (NCL) or Batten's disease are the most common juvenile neurodegenerative disease, characterized by early blindness, movement disorders, cognitive and behavioral impairment, epilepsy, and retinopathy. This study aims to collect clinical and laboratory data of patients with NCL taking Trehalose.
Detailed description
This study aims to collect clinical and laboratory data of patients with NCL taking Trehalose.
Conditions
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2021-07-01
- Completion
- 2021-10-01
- First posted
- 2021-03-22
- Last updated
- 2022-04-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04808297. Inclusion in this directory is not an endorsement.